Navigation

  • About
  • Resume
  • Research Fields
  • Enrollment and Training
  • Course
  • Scientific
  • Academic Achievements
  • Honor
头像

Xu Jin

  • About

    • Department:
    • Gender: male
    • Post:
    • Graduate School:
    • Degree:
    • Academic Credentials:
    • Tel: 021-62233223
    • Email: jxu@stat.ecnu.edu.cn
    • Office: A1712c Science Tower, 3663 North ZhongshanRoad
    • Address: School of Statistics，East China Normal University，3663 North Zhongshan Road， Shanghai 200062, China
    • PostCode:
    • Fax:

    WorkExperience

    2006.5 – present

    Asso. Professor/Professor, East China Normal University

    2005.6 – 2006.4

    Senior Scientist - Biostatistician, Ambion, Inc.

    2004.7 – 2005.6

    Postdoc, University of California-Riverside


    Education

    Ph.D.   (2004)

    Bowling Green StateUniversity

    B.S.   (1999)

    East China Normal University


    Resume

    Jin Xu is a professor of statistics in the school of statistics of East China Normal University. He received his PhD from Bowling Green State University. His research interests include statistical methods in clinical trials, multivariate analysis, and sequential designs.


    Other Appointments

    Research Fields

    Clinical trials, biostatistics, multivariate analysis

    Enrollment and Training

    Course

    biostatistics, multivariate analysis

    Scientific

    Academic Achievements

    • Dufera,A., Xiong,C., and Xu,J. (2023) Simultaneous confidence intervals from randomization tests with application in testing bioequivalence with multiple endpoints, Biometrical Journal, 65, 2200082.

    • Dufera,A., Liu,T., and Xu,J. (2023) Regression models of Pearson correlation coefficient, Statistical Theory and Related Fields, 7, 97-106.

    • Ditzhaus,M., Yu,M., and Xu,J. (2023) Studentized permutation method for comparing restricted mean survival times with small sample from randomized trials, Statistics in Medicine, 42, 2226-2240.

    • Dormuth,I., Liu,T., Xu,J., Pauly,M., and Ditzhaus,M. (2023) A comparative study to alternatives to the log-rank test, Contemporary Clinical Trials, 128, 107165.

    • Zhang,D. and Xu,J. (2023) A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy, Contemporary Clinical Trials, 127, 107203.

    • Xu,J., Zhang,D., and Mu,R. (2022) A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation, BMC Medical Research Methodology, 22, 258.

    • Bizuayehu,S.B. and Xu,J. (2022) Model-free screening for variables with treatment interaction, Statistical Methods in Medical Research, 31, 1845-1859.

    • Bizuayehu,S.B., Li,L., and Xu,J. (2022) Variable screening in multivariate linear regression with high dimensional covariates, Statistical Theory and Related Fields, 6, 241-253.

    • Belay,S.Y., Guo,X., Lin,X., Xia,F., and Xu,J. (2022) Bayesian basket trial design accounting for multiple cutoffs of an ambiguous biomarker, Statistics in Biopharmaceutical Research, 143, 342-348.

    • Dormuth,I., Liu,T., Xu,J., Yu,M., Pauly,M., and Ditzhaus,M.  (2022) Which test for crossing survival curves? A user’s guideline, BMC Medical Research Methodology, 22, 34.

    • Mu,R., Xu,J., Tang,R., Kopetz,S., and Yuan,Y. (2022) A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications, Statistics in Medicine, 41, 374-389.

    • Adall,S.W. and Xu,J. (2021) Bayesian shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trial, Pharmaceutical Statistics, 20, 1074-1087. 

    • Liu,T., Chen,Z., and Xu,J. (2021) Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in North China: an observational study, Journal of Medical Virology, 93, 6628-6633.

    • Belay,S.Y., Mu,R., and Xu,J. (2021) A Bayesian biosimilar trial design with time-to-event endpoint, Pharmaceutical Statistics, 20, 597-609.

    • Xu,J., Mu,R. and Xiong,C. (2021) A Bayesian stochastic approximation method, Journal of Statistical Planning and Inference, 211, 391-401.

    • Huang,X. and Xu,J. (2020) Estimating individualized treatment rules with risk constraint, Biometrics, 76, 1310-1318.

    • Liu,T., Ditzhaus,M., and Xu,J. (2020) A resampling-based test for two crossing survival curves, Pharmaceutical Statistics, 19, 399-409.

    • Huang,X., Goldberg,Y. and Xu,J. (2019) Multi-category individualized treatment regime using outcome weighted learning, Biometrics, 75, 1216-1227.

    • Mu,R., Yuan,Y., Xu,J., Mandrekar,S.J. and Yin,J. (2019) gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points, Journal of the Royal Statistical Society Series C, 68, 289-308.



    Honor